TP53 and hepatocellular carcinoma: Guan et al. conducted a controlled trial of rAd-p53 injection combined with hepatic arterial chemoembolization in the treatment of patients with advanced HCC and those who only received hepatic arterial chemoembolization, and the results showed that the p53 treatment group was significantly better than the control group.